• Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)

    5 days ago - By San Diego Biotechnology

    SAN DIEGO, Jan. 20, 2023 /PRNewswire/ - Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced that on January 20,...
    Read more ...